Respicardia’s remedē, a Pacemaker for Lungs, Now Treating First Sleep Apnea Patient

Last year the FDA granted Respicardia, a Minnetonka, Minnesota firm, approval to introduce its remedē System as a treatment option for severe central sleep apnea. Now the company is proudly reporting that the first patient to receive the newly commercialized phrenic nerve stimulating implant is already receiving treatment following surgery at Ohio (Read more...)

Full Story →